← Browse by Condition
Medical Condition
prosthetic joint infection
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3, Phase 4, Phase 1
ClinicalMetric tracks all active clinical trials for prosthetic joint infection sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — prosthetic joint infection Clinical Trials
How many clinical trials are currently recruiting for prosthetic joint infection?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for prosthetic joint infection, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for prosthetic joint infection?
prosthetic joint infection research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a prosthetic joint infection clinical trial?
Eligibility criteria for prosthetic joint infection trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05169229 Phase 2, Phase 3
Recruiting
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
Enrollment
1,100 pts
Location
Sweden
Sponsor
University Hospital, Linkoepin...
NCT06172010 Phase 4
Recruiting
Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Enrollment
316 pts
Location
Netherlands
Sponsor
Leiden University Medical Cent...
NCT05642013
Recruiting
SHort Interval Full Two-stage Implant Exchange
Enrollment
100 pts
Location
France
Sponsor
University Hospital, Montpelli...
NCT07324954 Phase 1
Recruiting
Methylene Blue in Total Knee Arthroplasty (TKA)
Enrollment
20 pts
Location
United States
Sponsor
University of Miami
NCT07406893
Recruiting
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
Enrollment
60 pts
Location
United States
Sponsor
St. Louis University
NCT04650607
Recruiting
Phage Safety Cohort Study
Enrollment
100 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06293352
Recruiting
Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
Enrollment
153 pts
Location
United States
Sponsor
Northwestern University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology